source
- Celcuity gains FDA approval for closely watched breast cancer drugStill, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.BioPharma Dive · 15d ago↗ source
- STAT+: In a major policy shift, Medicare proposes to ban vendors from providing remote monitoring servicesMedicare is proposing to ban vendors from providing remote patient monitoring services on behalf of doctors.STAT · 15d ago↗ source
- Merck ADC, in China study, shows potential to replace chemo in lung cancerThe results were seen by Wall Street analysts as “direct proof-of-concept” that sac-TMT, a drug Merck views as a “cornerstone,” could be part of a future treatment standard for front-line lung cancer.